IRMD - Company ID 0001325618
The table below shows IRADIMED CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $8.29M | $4.29M | $3.88M | $4.65M | $1.43M | $943.08K |
| Capital expenditure | $403.00K | $3.70M | $270.57K | $6.40M | $183.35K | $132.32K |
| Investing cash flow | -$469.00K | -$3.92M | -$478.80K | -$6.56M | -$424.69K | -$173.93K |
| Dividends paid | $2.56M | $2.16M | $7.98M | $13.22M |
IRADIMED CORP reported operating cash flow of $24.95M for fiscal year 2025. That is down 2.6% from $25.62M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $9.41M (FY 2016) to $24.95M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $12.56M |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$2.61M | -$2.28M | -$8.04M | -$13.27M | -$12.55M | -$36.25K |